glp 1 pediatric obesity GLP-1 receptor agonists in and diabetes: a systematic review of efficacy, metabolic effects, and safety Ozempic and Wegovy for kids:

and increased insulin early AUC and C-peptide total and early AUCs

Purpose of Review This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor (GLP-1R) agonists, tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding indications in cardiovascular, renal, and metabolic health

Saffron patented Safr'Inside SafrInside is a patented saffron extract, standardized in crocins and safranal, that supports emotional balance by promoting a positive mood

Victoza (liraglutide) is a once-daily injectable medication used to treat type 2 diabetes

A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight loss was associated with a marked drop in drinking over 10 months, with his AUDIT score falling from 27 to 7 and alcohol use dropping from about 15 drinks per week to half a beer per month

With an FY18 Multiple Sclerosis Research Program Investigator-Initiated Research Award, Dr